Found 548614 clinical trials
Sort by:
A Mindfulness-based Intervention to Reduce Stress and Improve Prosocial Skills for Health-care Students
Not Applicable
Completed
- Conditions
- Mental Health Issue
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- University of Geneva, Switzerland
- Target Recruit Count
- 161
- Registration Number
- NCT07110792
- Locations
- 🇨🇭
University of Geneva, Geneva, Switzerland
Teclistamab-Daratumumab in AL Amyloidosis
Not Applicable
Not yet recruiting
- Conditions
- Amyloid Light-chain Amyloidosis
- Interventions
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Suzanne Lentzsch, MD
- Target Recruit Count
- 25
- Registration Number
- NCT07110844
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors
Recruiting
- Conditions
- Bone and Soft Tissue TumorsBone Metastases From Solid TumorsLung Metastases
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Istituto Ortopedico Rizzoli
- Target Recruit Count
- 125
- Registration Number
- NCT07112989
- Locations
- 🇮🇹
Istituto Ortopedico Rizzoli, Bologna, Italy
The Effect of Virtual Reality on Cognitive Skills in Schizophrenia
Not Applicable
Completed
- Conditions
- Cognitive Ability GeneralVirtual RealityVirtual Reality Cognitive TrainingSchizophrenia Disorder
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Saglik Bilimleri Universitesi
- Target Recruit Count
- 114
- Registration Number
- NCT07111689
- Locations
- 🇹🇷
University of Health Science, Ankara, Turkey
Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster Headache
Not Applicable
Not yet recruiting
- Conditions
- Chronic Cluster Headache
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Salvia BioElectronics
- Target Recruit Count
- 10
- Registration Number
- NCT07113470
A Placebo-controlled Trial of Fractional Flow Reserve-guided Percutaneous Renal Artery Stenting Among Atherosclerosis Renal-vascular Hypertension Patients
Not Applicable
Not yet recruiting
- Conditions
- Renal Artery Stenosis AtheroscleroticSecondary Hypertension Renal Arterial
- Interventions
- Diagnostic Test: renal artery fractional flow reserve measurementDevice: renal artery stentOther: sham stenting
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT07111442
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
The Effects of a Foam Rolling Protocol on Ankle Range of Motion, Ankle Stability, and Athletic Performance in Elite Rhythmic Gymnasts
Not Applicable
Completed
- Conditions
- Athletes
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- University of Palermo
- Target Recruit Count
- 26
- Registration Number
- NCT07113249
- Locations
- 🇮🇹
University of Palermo, Palermo, Italy
Study of High-risk Prostate Cancer About Predicting Lymph Node Metastasis by Artificial Intelligence Multi-omics Analysis
Not yet recruiting
- Conditions
- Prostate CancerArtifical IntelligenceLymph Node Cancer Metastatic
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Not specified
- Target Recruit Count
- 2000
- Registration Number
- NCT07112599
Intravenous Tirofiban After Delayed Thrombolysis in Stroke
Not Applicable
Not yet recruiting
- Conditions
- Acute Ischemic Stroke
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Target Recruit Count
- 852
- Registration Number
- NCT07111806
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease
Not Applicable
Not yet recruiting
- Conditions
- Dry Eye Disease
- Interventions
- Drug: Lifitegrast/perfluorohexyloctane (PFHO)
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 150
- Registration Number
- NCT07111013